S -Nitrosoglutathione Reduces Asymptomatic Embolization After Carotid Angioplasty
Authors:
- 10 December 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (24) , 3057-3062
Abstract
Background— The major complication of carotid angioplasty is embolic stroke, which may occur after balloon inflation and deflation or in the early postintervention period. Platelet adhesion and aggregation to the angioplasty site with subsequent embolization seems to plays a major role in early postangioplasty embolization and stroke. During this period, asymptomatic embolic signals can be detected in patients by transcranial Doppler ultrasound despite aspirin and heparin treatment. S -Nitrosoglutathione (GSNO) is a nitric oxide donor that appears to have relative platelet specificity. We evaluated its effectiveness in reducing embolization after carotid angioplasty. Methods and Results— Sixteen patients undergoing carotid angioplasty and stenting for symptomatic ≥70% internal carotid artery stenosis were randomized in a double-blind manner to GSNO or placebo given after surgery for 90 minutes. All patients were pretreated with aspirin and given heparin for 24 hours after the procedure. Transcranial Doppler recordings were made from the ipsilateral middle cerebral artery for 1 hour before treatment and at 0 to 3, 6, and 24 hours after treatment. GSNO resulted in a rapid reduction in the frequency of embolic signals of 95% at 0 to 3 hours and 100% at 6 hours ( P =0.007 and P =0.01 versus placebo, respectively). In the placebo group, 2 patients experienced ipsilateral stroke after the angioplasty. No cerebrovascular events occurred in the GSNO group. Conclusions— S -Nitrosoglutathione was highly effective in rapidly reducing the frequency of embolic signals after endovascular treatment for symptomatic high-grade carotid stenosis.Keywords
This publication has 13 references indexed in Scilit:
- Intracerebral Hemorrhages Associated With Neurointerventional Procedures Using a Combination of Antithrombotic Agents Including AbciximabStroke, 2002
- Formation of nanomolar concentrations of S-nitroso-albumin in human plasma by nitric oxideFree Radical Biology and Medicine, 2001
- Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trialThe Lancet, 2001
- Global experience in cervical carotid artery stent placementCatheterization and Cardiovascular Interventions, 2000
- Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: An ex vivo analysisJournal of Vascular Surgery, 1999
- Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST)The Lancet, 1998
- Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplastyThe Lancet, 1994
- ENDOGENOUS NITRIC OXIDE INHIBITS HUMAN PLATELET ADHESION TO VASCULAR ENDOTHELIUMThe Lancet, 1987
- Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in plateletsBritish Journal of Pharmacology, 1987
- Comparative Effects of Nitroprusside and Nitroglycerin on Platelet Aggregation in Patients with Heart FailureJournal of Cardiovascular Pharmacology, 1980